Arja L Karjalainen

This inventor holds 6 USPTO granted patents. Top assignees: Farmos-Yhtyma Oy, Orion-Yhtyma Oy. Active years: 1987-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arja L Karjalainen. Retrieved from https://idiyas.com/inventor/arja-l-karjalainen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 14(Granted Patents)

Company Filing History:

Years Active: 1987-1996

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5498623 - 4(5) substituted imidazoles and their preparation and use (1996-03-12),

2. 5439928 - Aromatase inhibiting 4(5)-imidazoles (1995-08-08),

3. 5292887 - Substituted imidazole derivatives and their preparation and use (1994-03-08),

4. 5026868 - Indenyl imidazoles (1991-06-25),

5. 4933359 - 4(5)-substituted imidazole derivatives as .alpha..sub.2 -adrenergic (1990-06-12),

6. 4689339 - 4-dihydroinden-2-yl-, 4-tetrahydronaphth-2-yl-, and (1987-08-25),

Title: Arja L Karjalainen: Innovator in Aromatase Inhibitors

Introduction

Arja L Karjalainen is a prominent inventor based in Oulu, Finland. She has made significant contributions to the field of medicinal chemistry, particularly in the development of aromatase inhibitors. With a total of six patents to her name, her work has the potential to impact the treatment of estrogen-dependent diseases, such as breast cancer.

Latest Patents

Among her latest patents are the innovations related to 4(5) substituted imidazoles and their preparation and use. These novel 4(5)-imidazole derivatives possess selective aromatase inhibiting properties, which are valuable in the treatment of various estrogen-dependent diseases. The specific formula of these compounds and their non-toxic salts highlight their potential therapeutic applications.

Career Highlights

Throughout her career, Arja has worked with notable companies, including Farmos-yhtyma Oy and Orion-yhtyma Oy. Her experience in these organizations has allowed her to refine her expertise in drug development and innovation.

Collaborations

Arja has collaborated with several professionals in her field, including Arto J Karjalainen and Raimo E Virtanen. These collaborations have contributed to her success and the advancement of her research.

Conclusion

Arja L Karjalainen is a distinguished inventor whose work in aromatase inhibitors has the potential to make a significant impact on the treatment of breast cancer and other estrogen-dependent diseases. Her contributions to medicinal chemistry are noteworthy and continue to inspire future innovations.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]